Kyowa Kirin To Offload Selected Mature Portfolio To Grünenthal

New JV Set For '26 Buy-Out

The Japanese and German firms agree to establish a joint company to handle 13 mature brands from Kyowa Kirin's portfolio, mainly focused on pain management and including Abstral and PecFent. Grünenthal will own 51% and plans to fully buy out the operation in early 2026.

Kyowa Kirin and Grünenthal
Grünenthal and Kyowa Kirin enter JV for Japanese firm's established medicines • Source: Shutterstock

Kyowa Kirin Co., Ltd. has signed a collaboration with private German firm Grünenthal GmbH to set up a joint venture to which the Japanese company will transfer 13 of its mature brands in six therapeutic areas in seven major European and other selected global markets.

The products, mainly in the pain management area, are currently sold through Kyowa Kirin affiliates and partners and had approximately...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip